Press Coverage
Sofinnova Crossover
Tom Burt, partner at Sofinnova Partners, speaks at Edison Group’s Open House Global Healthcare Event
Related Strategy
CrossoverTom Burt, partner at Sofinnova Partners, joined Edison Group’s Open House Global Healthcare Event. His panel discussed some of the scenarios that are likely to play out in 2022 for biotech in public and private equity markets and M&A. View the replay here.
Related News
Mainstay Medical announces exclusive coverage of ReActiv8® by Anthem Blue Cross/Blue Shield
Mainstay Medical announces positive outcomes from landmark RESTORE clinical trial of ReActiv8®
Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
Sensorion reports new positive clinical results presented at the World Congress of Audiology
F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US